JP2018502872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502872A5 JP2018502872A5 JP2017538226A JP2017538226A JP2018502872A5 JP 2018502872 A5 JP2018502872 A5 JP 2018502872A5 JP 2017538226 A JP2017538226 A JP 2017538226A JP 2017538226 A JP2017538226 A JP 2017538226A JP 2018502872 A5 JP2018502872 A5 JP 2018502872A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- aqueous pharmaceutical
- injectable aqueous
- composition according
- mda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562106045P | 2015-01-21 | 2015-01-21 | |
| US62/106,045 | 2015-01-21 | ||
| PCT/US2016/014165 WO2016118649A1 (en) | 2015-01-21 | 2016-01-20 | Pharmaceutical formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020008235A Division JP7065129B2 (ja) | 2015-01-21 | 2020-01-22 | 医薬製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502872A JP2018502872A (ja) | 2018-02-01 |
| JP2018502872A5 true JP2018502872A5 (https=) | 2019-02-14 |
| JP6829201B2 JP6829201B2 (ja) | 2021-02-10 |
Family
ID=55405453
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017538226A Active JP6829201B2 (ja) | 2015-01-21 | 2016-01-20 | 医薬製剤 |
| JP2020008235A Active JP7065129B2 (ja) | 2015-01-21 | 2020-01-22 | 医薬製剤 |
| JP2021105585A Active JP7269992B2 (ja) | 2015-01-21 | 2021-06-25 | 医薬製剤 |
| JP2021143727A Pending JP2021183649A (ja) | 2015-01-21 | 2021-09-03 | 医薬製剤 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020008235A Active JP7065129B2 (ja) | 2015-01-21 | 2020-01-22 | 医薬製剤 |
| JP2021105585A Active JP7269992B2 (ja) | 2015-01-21 | 2021-06-25 | 医薬製剤 |
| JP2021143727A Pending JP2021183649A (ja) | 2015-01-21 | 2021-09-03 | 医薬製剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10500284B2 (https=) |
| EP (2) | EP3925597A1 (https=) |
| JP (4) | JP6829201B2 (https=) |
| KR (2) | KR102600792B1 (https=) |
| CN (2) | CN107205926B (https=) |
| AU (1) | AU2016209332B2 (https=) |
| BR (1) | BR112017015452B1 (https=) |
| CA (1) | CA2974657C (https=) |
| ES (1) | ES2877371T7 (https=) |
| IL (1) | IL253570B (https=) |
| MX (2) | MX386732B (https=) |
| TW (3) | TWI674899B (https=) |
| WO (1) | WO2016118649A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI624262B (zh) | 2013-01-23 | 2018-05-21 | 桑紐爾製藥公司 | 醫藥配方 |
| TWI674899B (zh) | 2015-01-21 | 2019-10-21 | 美商桑紐爾製藥公司 | 醫藥配方 |
| HK1253778A1 (zh) * | 2015-06-02 | 2019-07-05 | Intravital Pty Ltd | 用於限制神经创伤的制剂和方法 |
| US12083138B2 (en) | 2018-07-09 | 2024-09-10 | Taiwan Liposome Co., Ltd. | Methods to reduce complications of intra-articular steroid |
| IT201800010415A1 (it) * | 2018-11-19 | 2020-05-19 | Innate S R L | Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione. |
| CN112870155B (zh) * | 2021-03-08 | 2023-06-30 | 上海昱聚科技有限公司 | 缓释地塞米松药物的凝胶注射剂及其制备方法和应用 |
| WO2024159191A1 (en) * | 2023-01-26 | 2024-08-02 | Insignia Pharmaceuticals, Llc | Pharmaceutical compositions for treating osteoarthritis |
| WO2025219919A1 (en) * | 2024-04-19 | 2025-10-23 | Beam Medical Inc. | Anesthetic pharmaceutical compositions, kits and uses thereof for slow release of an anesthetic agent and concurrent medical imaging of its distribution |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL25251A (en) | 1965-07-20 | 1969-11-12 | Merck & Co Inc | Aqueous mixtures for ophthalmology based on hydroxyethylcellulose and a method for their preparation |
| US3962430A (en) | 1974-08-07 | 1976-06-08 | Merck & Co., Inc. | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride |
| US4304765A (en) | 1980-10-14 | 1981-12-08 | Alza Corporation | Ocular insert housing steroid in two different therapeutic forms |
| EP0244178A3 (en) | 1986-04-28 | 1989-02-08 | Iolab, Inc | Intraocular dosage compositions and method of use |
| IL80298A (en) * | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| FI105075B (fi) | 1996-01-10 | 2000-06-15 | Suprakort Oy | Kombinaatioinjektiovalmisteen käyttö |
| IT1288290B1 (it) * | 1996-06-21 | 1998-09-11 | Fidia Spa In Amministrazione S | Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie |
| JPH11279065A (ja) * | 1998-03-25 | 1999-10-12 | Shiseido Co Ltd | 局所投与炎症治療剤 |
| US6921532B1 (en) | 2000-06-22 | 2005-07-26 | Spinal Restoration, Inc. | Biological Bioadhesive composition and methods of preparation and use |
| US6747090B2 (en) | 2001-07-16 | 2004-06-08 | Pharmacia Groningen Bv | Compositions capable of forming hydrogels in the eye |
| US20040006052A1 (en) | 2002-04-15 | 2004-01-08 | Gudas Charles J. | Injection solutions to treat neuropathic symptoms and other sensorimotor disorders that are due to neuromas of the foot or other entrapment neuropathies of peripheral nerves, and method of use |
| US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| CN101094690A (zh) * | 2003-11-12 | 2007-12-26 | 阿勒根公司 | 用于治疗眼后节的组合物及方法 |
| US20050186229A1 (en) | 2004-02-24 | 2005-08-25 | Emmett Clemente | Pleasant-tasting aqueous liquid composition of prednisolone sodium phosphate |
| JP2007001926A (ja) | 2005-06-24 | 2007-01-11 | Ltt Bio-Pharma Co Ltd | 吸入・噴霧用ステロイド製剤 |
| JP4969812B2 (ja) | 2005-07-22 | 2012-07-04 | 久光製薬株式会社 | ハイドロゲル組成物 |
| US20070099882A1 (en) | 2005-10-27 | 2007-05-03 | Gurney Harry C | Methods and compositions for prolonged alleviation of articular joint pain |
| CA2633957A1 (en) * | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| US20070141160A1 (en) | 2005-12-15 | 2007-06-21 | Brown Laura J | Method of treatment for osteoarthritis by local intra-articular injection of microparticles |
| CN100534434C (zh) | 2006-05-15 | 2009-09-02 | 西安力邦制药有限公司 | 透明质酸钠地塞米松脂肪乳制剂及其应用 |
| WO2008057364A1 (en) * | 2006-11-02 | 2008-05-15 | Riolan Technologies, Inc. | Method for treating blepharitis |
| US20080317805A1 (en) * | 2007-06-19 | 2008-12-25 | Mckay William F | Locally administrated low doses of corticosteroids |
| US9421356B2 (en) | 2007-08-28 | 2016-08-23 | Teikoku Pharma Usa, Inc. | Transdermal methods and systems for the delivery of corticosteroid compounds |
| US20090143348A1 (en) | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
| US20090143807A1 (en) | 2007-12-03 | 2009-06-04 | Vertos Medical, Inc., A Delaware Corporation | Percutaneous Devices for Separating Tissue, Kits and Methods of Using the Same |
| CN101918002B (zh) | 2008-04-18 | 2013-06-26 | 麦德托尼克公司 | 治疗椎间盘突出的方法及组合物 |
| KR101534422B1 (ko) | 2008-05-14 | 2015-07-09 | 오토노미, 인코포레이티드 | 귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법 |
| CN101683532A (zh) * | 2008-09-25 | 2010-03-31 | 武汉诺安药业有限公司 | 含玻璃酸或其盐的眼用复方药物制剂 |
| EP2365812A4 (en) | 2008-11-10 | 2012-05-16 | Nitric Biotherapeutics Inc | PHARMACEUTICAL FORMULATIONS FOR THE IONTOPHORETIC DELIVERY OF A CORTICOSTEROID |
| UA111162C2 (uk) | 2010-08-04 | 2016-04-11 | Флекшен Терап'Ютікс, Інк. | Ін'єкційна композиція ацетоніду триамцинолону для лікування болю |
| RU2459615C1 (ru) | 2011-03-05 | 2012-08-27 | Илья Александрович Марков | Глазные капли для лечения болезни сухого глаза |
| RU2014127492A (ru) | 2011-12-06 | 2016-02-10 | Алькон Рисерч, Лтд. | Композиции целлюлозного геля с улучшенной стабильностью вязкости |
| US20130165419A1 (en) | 2011-12-21 | 2013-06-27 | Insite Vision Incorporated | Combination anti-inflammatory ophthalmic compositions |
| TWI624262B (zh) * | 2013-01-23 | 2018-05-21 | 桑紐爾製藥公司 | 醫藥配方 |
| TWI674899B (zh) | 2015-01-21 | 2019-10-21 | 美商桑紐爾製藥公司 | 醫藥配方 |
-
2016
- 2016-01-13 TW TW105100928A patent/TWI674899B/zh active
- 2016-01-13 TW TW111124453A patent/TWI845973B/zh active
- 2016-01-13 TW TW108125361A patent/TWI772659B/zh active
- 2016-01-20 KR KR1020177023066A patent/KR102600792B1/ko active Active
- 2016-01-20 CN CN201680006518.3A patent/CN107205926B/zh active Active
- 2016-01-20 CN CN202110187457.8A patent/CN112957320A/zh active Pending
- 2016-01-20 BR BR112017015452-8A patent/BR112017015452B1/pt active IP Right Grant
- 2016-01-20 EP EP21173943.8A patent/EP3925597A1/en active Pending
- 2016-01-20 MX MX2017009482A patent/MX386732B/es unknown
- 2016-01-20 EP EP16705864.3A patent/EP3247329B3/en active Active
- 2016-01-20 JP JP2017538226A patent/JP6829201B2/ja active Active
- 2016-01-20 US US15/545,204 patent/US10500284B2/en active Active
- 2016-01-20 WO PCT/US2016/014165 patent/WO2016118649A1/en not_active Ceased
- 2016-01-20 ES ES16705864T patent/ES2877371T7/es active Active
- 2016-01-20 KR KR1020237038308A patent/KR102824858B1/ko active Active
- 2016-01-20 AU AU2016209332A patent/AU2016209332B2/en active Active
- 2016-01-20 CA CA2974657A patent/CA2974657C/en active Active
-
2017
- 2017-07-19 IL IL253570A patent/IL253570B/en active IP Right Grant
- 2017-07-20 MX MX2021012029A patent/MX2021012029A/es unknown
-
2018
- 2018-02-27 US US15/907,057 patent/US10117938B2/en active Active
-
2019
- 2019-10-29 US US16/667,297 patent/US11020485B2/en active Active
-
2020
- 2020-01-22 JP JP2020008235A patent/JP7065129B2/ja active Active
-
2021
- 2021-04-29 US US17/244,348 patent/US12285485B2/en active Active
- 2021-06-25 JP JP2021105585A patent/JP7269992B2/ja active Active
- 2021-09-03 JP JP2021143727A patent/JP2021183649A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502872A5 (https=) | ||
| US11364251B2 (en) | Pharmaceutical formulation | |
| JP2021143209A5 (https=) | ||
| US8128960B2 (en) | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection | |
| JP2016510329A5 (https=) | ||
| TWI674899B (zh) | 醫藥配方 | |
| AU2016375866A1 (en) | Formulations of phosphoramidate derivatives of nucleoside drugs | |
| JP2017529388A5 (https=) | ||
| Hooten et al. | Serum triamcinolone levels following interlaminar epidural injection | |
| Jurgens et al. | The use of conventional disease-modifying anti-rheumatic drugs in established RA | |
| HK40056968A (en) | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | |
| BANIHASHEMI et al. | Investigation of effect of various drug loading and addition of a rate modifying agent on famotidine release from in situ forming implants | |
| HK1245653B (en) | Injectable pharmaceutical composition comprising dexamethasone sodium phosphate | |
| HK1146464B (en) | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |